Knopp Biosciences Reported Steroid-sparing Effects of Dexpramipexole in HES at American Society of Hematology 2016 Annual Meeting
Knopp Biosciences LLC today announced the presentation of data from an ongoing, open-label pilot-study of dexpramipexole in hypereosinophilic syndromes (HES) demonstrating hematological responses, symptom improvement, and steroid sparing in a subset of subjects with steroid-dependent HES. Full results from the … Continued